our partners in the civil society

riboxx pharmaceuticals has successfully run a crowdfunding campaign in 2014. The campaing aimed at raising EUR 1 million for the manufacturing of GMP TLR3 ligand RIBOXXIM and clinical testing in cancer patients (Phase I/IIa).

The crowdfunding campaign mobilized around 1000 investors (so called "LIFEinvestors") that contributed to achieve the investment of EUR 1 million.